Riverbridge Partners LLC Sells 5,271 Shares of Roche Holding AG (OTCMKTS:RHHBY)

Riverbridge Partners LLC reduced its stake in Roche Holding AG (OTCMKTS:RHHBY) by 12.9% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 35,445 shares of the company’s stock after selling 5,271 shares during the quarter. Riverbridge Partners LLC’s holdings in Roche were worth $1,236,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds also recently bought and sold shares of the stock. Brooklyn Investment Group purchased a new stake in shares of Roche in the third quarter worth $40,000. AlphaMark Advisors LLC purchased a new stake in Roche in the 3rd quarter worth $149,000. IHT Wealth Management LLC bought a new stake in Roche during the third quarter valued at about $236,000. Verity Asset Management Inc. bought a new position in shares of Roche in the third quarter worth about $253,000. Finally, Canopy Partners LLC grew its position in shares of Roche by 4.6% during the third quarter. Canopy Partners LLC now owns 7,772 shares of the company’s stock worth $310,000 after purchasing an additional 344 shares in the last quarter.

Roche Stock Up 1.0 %

RHHBY opened at $37.85 on Thursday. Roche Holding AG has a fifty-two week low of $29.20 and a fifty-two week high of $42.43. The company has a quick ratio of 0.97, a current ratio of 1.26 and a debt-to-equity ratio of 0.86. The company has a fifty day moving average of $35.76 and a 200 day moving average of $38.10.

Roche Profile

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and Oceania. The company offers pharmaceutical products in the therapeutic areas of anemia, blood and solid tumors, dermatology, hemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation.